Background: Inflammatory bowel disease (IBD), once considered to be a Western disease, is increasingly being reported from India and other Asian countries. The present review summarizes epidemiology and disease characteristics of IBD in India with reference to other Asian countries and the West. Summary: India is projected to have one of the highest disease burden of IBD across the globe. The overall genetic risk and microbial signature in Indian IBD patients are similar to those of patients in the West as demonstrated by the similar incidence of IBD in second-generation Indian immigrants and matching perturbations in the structural and functional component of gut microbiota in Indian studies. The concept of the hygiene hypothesis continues to remain controversial with Indian studies demonstrating contradictory findings. The disease characteristics, long-term outcomes including the risk of colorectal cancer, and the effect of pregnancy on IBD and vice versa in Indian patients with IBD are in general similar with few differences. Unlike patients in the West, very few Indian patients have a positive family history. Key Message: The Indian disease pattern is going through a phase of epidemiological transition with a surge in the incidence of IBD. The epidemiology and disease characteristics of IBD mirror the patterns observed in the West.

Keywords:
Pregnancy, Genetics, Crohn disease, Colorectal cancer, Ulcerative colitis
1.
Ahuja V, Tandon RK: Inflammatory bowel disease: the Indian augury. Indian J Gastroenterol 2012;31:294-296.
2.
Tandon BN, Mathur AK, Mohapatra LN, Tandon HD, Wig KL: A study of the prevalence and clinical pattern of non-specific ulcerative colitis in northern India. Gut 1965;6:448-453.
3.
Khosla SN, Girdhar NK, Lal S, Mishra DS: Epidemiology of ulcerative colitis in hospital and select general population of northern India. J Assoc Physicians India 1986;34:405-407.
4.
Sood A, Midha V, Sood N, Bhatia AS, Avasthi G: Incidence and prevalence of ulcerative colitis in Punjab, North India. Gut 2003;52:1587-1590.
5.
Ng SC, Tang W, Ching JY, et al; Asia-Pacific Crohn's and Colitis Epidemiologic Study (ACCESS) Study Group: Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology 2013;145:158-165.
6.
Al-Shamali MA, Kalaoui M, Patty I, Hasan F, Khajah A, Al-Nakib B: Ulcerative colitis in Kuwait: a review of 90 cases. Digestion 2003;67:218-224.
7.
Tezel A, Dökmeci G, Eskiocak M, Umit H, Soylu AR: Epidemiological features of ulcerative colitis in Trakya, Turkey. J Int Med Res 2003;31:141-148.
8.
Niv Y, Abuksis G, Fraser GM: Epidemiology of ulcerative colitis in Israel: a survey of Israeli kibbutz settlements. Am J Gastroenterol 2000;95:693-698.
9.
Das K, Ghoshal UC, Dhali GK, Benjamin J, Ahuja V, Makharia GK: Crohn's disease in India: a multicenter study from a country where tuberculosis is endemic. Dig Dis Sci 2009;54:1099-1107.
10.
Hou JK, El-Serag H, Thirumurthi S: Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review. Am J Gastroenterol 2009;104:2100-2109.
11.
Yang SK, Loftus EV Jr, Sandborn WJ: Epidemiology of inflammatory bowel disease in Asia. Inflamm Bowel Dis 2001;7:260-270.
12.
Thia KT, Loftus EV Jr, Sandborn WJ, Yang SK: An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol 2008;103:3167-3182.
13.
Abramson O, Durant M, Mow W, et al: Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996-2006. J Pediatr 2010;157:233-239.
14.
Ahuja V, Tandon RK: Inflammatory bowel disease in the Asia-Pacific area: a comparison with developed countries and regional differences. J Dig Dis 2010;11:134-147.
15.
Molodecky NA, Soon IS, Rabi DM, et al: Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142:46-54.
16.
Loftus EV Jr: Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504-1517.
17.
Loftus CG, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Tremaine WJ, Melton LJ 3rd, Sandborn WJ: Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis 2007;13:254-261.
18.
Langholz E, Munkholm P, Nielsen OH, Kreiner S, Binder V: Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987. Scand J Gastroenterol 1991;26:1247-1256.
19.
Lok KH, Hung HG, Ng CH, et al: Epidemiology and clinical characteristics of ulcerative colitis in Chinese population: experience from a single center in Hong Kong. J Gastroenterol Hepatol 2008;23:406-410.
20.
Sung JJ, Hsu RK, Chan FK, Liew CT, Lau JW, Li AK: Crohn's disease in the Chinese population. An experience from Hong Kong. Dis Colon Rectum 1994;37:1307-1309.
21.
Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M: Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996;39:690-697.
22.
Khalili H, Huang ES, Ananthakrishnan AN, et al: Geographical variation and incidence of inflammatory bowel disease among US women. Gut 2012;61:1686-1692.
23.
Makharia GK, Ramakrishna BS, Abraham P, et al; Indian Society of Gastroenterology Task Force on Inflammatory Bowel Disease: Survey of inflammatory bowel diseases in India. Indian J Gastroenterol 2012;31:299-306.
24.
Nerich V, Jantchou P, Boutron-Ruault MC, et al: Low exposure to sunlight is a risk factor for Crohn's disease. Aliment Pharmacol Ther 2011;33:940-945.
25.
Chouraki V, Savoye G, Dauchet L, et al: The changing pattern of Crohn's disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988-2007). Aliment Pharmacol Ther 2011;33:1133-1142.
26.
Yang SK, Yun S, Kim JH, et al: Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm Bowel Dis 2008;14:542-549.
27.
Thia KT, Luman W, Jin OC: Crohn's disease runs a more aggressive course in young Asian patients. Inflamm Bowel Dis 2006;12:57-61.
28.
Tsironi E, Feakins RM, Probert CS, Rampton DS, Phil D: Incidence of inflammatory bowel disease is rising and abdominal tuberculosis is falling in Bangladeshis in East London, United Kingdom. Am J Gastroenterol 2004;99:1749-1755.
29.
Singh P, Ananthakrishnan A, Ahuja V: Pivot to Asia: inflammatory bowel disease burden. Intest Res 2017;15:138-141.
30.
Probert CS, Jayanthi V, Pinder D, Wicks AC, Mayberry JF: Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut 1992;33:687-693.
31.
Jayanthi V, Probert CS, Pinder D, Wicks AC, Mayberry JF: Epidemiology of Crohn's disease in Indian migrants and the indigenous population in Leicestershire. Q J Med 1992;82:125-138.
32.
Benchimol EI, Mack DR, Guttmann A, et al: Inflammatory bowel disease in immigrants to Canada and their children: a population-based cohort study. Am J Gastroenterol 2015;110:553-563.
33.
Jostins L, Ripke S, Weersma RK, et al: International IBD Genetics Consortium (IIBDGC), Silverberg MS, Annese V, Hakonarson H, Brant SR, Radford-Smith G, Mathew CG, Rioux JD, Schadt EE, Daly MJ, Franke A, Parkes M, Vermeire S, Barrett JC, Cho JH: Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012;491:119-124.
34.
Liu JZ, van Sommeren S, Huang H, et al: Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet 2015;47:979-986.
35.
Pugazhendhi S, Amte A, Balamurugan R, Subramanian V, Ramakrishna BS: Common NOD2 mutations are absent in patients with Crohn's disease in India. Indian J Gastroenterol 2008;27:201-203.
36.
Mahurkar S, Banerjee R, Rani VS, et al: Common variants in NOD2 and IL23R are not associated with inflammatory bowel disease in Indians. J Gastroenterol Hepatol 2011;26:694-699.
37.
Pugazhendhi S, Santhanam S, Venkataraman J, Creveaux I, Ramakrishna BS: NOD2 gene mutations associate weakly with ulcerative colitis but not with Crohn's disease in Indian patients with inflammatory bowel disease. Gene 2013;512:309-313.
38.
Juyal G, Prasad P, Senapati S, Midha V, Sood A, Amre D, Juyal RC, BK T: An investigation of genome-wide studies reported susceptibility loci for ulcerative colitis shows limited replication in north Indians. PLoS One 2011;6:e16565.
39.
Baskaran K, Pugazhendhi S, Ramakrishna BS: Protective association of tumor necrosis factor superfamily 15 (TNFSF15) polymorphic haplotype with Ulcerative Colitis and Crohn's disease in an Indian population. PLoS One 2014;9:e114665.
40.
Yamazaki K, McGovern D, Ragoussis J, et al: Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet 2005;14:3499-3506.
41.
Thiébaut R, Kotti S, Jung C, et al: TNFSF15 polymorphisms are associated with susceptibility to inflammatory bowel disease in a new European cohort. Am J Gastroenterol 2009;104:384-391.
42.
Baskaran K, Pugazhendhi S, Ramakrishna BS: Association of IRGM gene mutations with inflammatory bowel disease in the Indian population. PLoS One 2014;9:e106863.
43.
Verma R, Ahuja V, Paul J: Detection of single-nucleotide polymorphisms in the intron 9 region of the nucleotide oligomerization domain-1 gene in ulcerative colitis patients of North India. J Gastroenterol Hepatol 2012;27:96-103.
44.
Verma R, Ahuja V, Paul J: Frequency of single nucleotide polymorphisms in NOD1 gene of ulcerative colitis patients: a case-control study in the Indian population. BMC Med Genet 2009;10:82.
45.
Meena NK, Verma R, Verma N, Ahuja V, Paul J: TLR4 D299G polymorphism modulates cytokine expression in ulcerative colitis. J Clin Gastroenterol 2013;47:773-780.
46.
Meena NK, Ahuja V, Meena K, Paul J: Association of TLR5 gene polymorphisms in ulcerative colitis patients of north India and their role in cytokine homeostasis. PLoS One 2015;10:e0120697.
47.
Juyal G, Midha V, Amre D, Sood A, Seidman E, Thelma BK: Associations between common variants in the MDR1 (ABCB1) gene and ulcerative colitis among North Indians. Pharmacogenet Genomics 2009;19:77-85.
48.
Ahirwar DK, Kesarwani P, Singh R, Ghoshal UC, Mittal RD: Role of tumor necrosis factor-alpha (C-863A) polymorphism in pathogenesis of inflammatory bowel disease in Northern India. J Gastrointest Cancer 2012;43:196-204.
49.
Juyal G, Negi S, Sood A, et al: Genome-wide association scan in north Indians reveals three novel HLA-independent risk loci for ulcerative colitis. Gut 2015;64:571-579.
50.
Tosa M, Negoro K, Kinouchi Y, et al: Lack of association between IBD5 and Crohn's disease in Japanese patients demonstrates population-specific differences in inflammatory bowel disease. Scand J Gastroenterol 2006;41:48-53.
51.
Yamazaki K, Takazoe M, Tanaka T, Kazumori T, Nakamura Y: Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J Hum Genet 2002;47:469-472.
52.
Strober W, Fuss I, Mannon P: The fundamental basis of inflammatory bowel disease. J Clin Invest 2007;117:514-521.
53.
Sheehan D, Moran C, Shanahan F: The microbiota in inflammatory bowel disease. J Gastroenterol 2015;50:495-507.
54.
Verma R, Verma AK, Ahuja V, Paul J: Real-time analysis of mucosal flora in patients with inflammatory bowel disease in India. J Clin Microbiol 2010;48:4279-4282.
55.
Conte MP, Schippa S, Zamboni I, et al: Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut 2006;55:1760-1767.
56.
Ott SJ, Plamondon S, Hart A, et al: Dynamics of the mucosa-associated flora in ulcerative colitis patients during remission and clinical relapse. J Clin Microbiol 2008;46:3510-3513.
57.
Zhang M, Liu B, Zhang Y, Wei H, Lei Y, Zhao L: Structural shifts of mucosa-associated lactobacilli and Clostridium leptum subgroup in patients with ulcerative colitis. J Clin Microbiol 2007;45:496-500.
58.
Andoh A, Imaeda H, Aomatsu T, et al: Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis. J Gastroenterol 2011;46:479-486.
59.
van der Wiel-Korstanje JA, Winkler KC: The faecal flora in ulcerative colitis. J Med Microbiol 1975;8:491-501.
60.
Kumari R, Ahuja V, Paul J: Fluctuations in butyrate-producing bacteria in ulcerative colitis patients of North India. World J Gastroenterol 2013;19:3404-3414.
61.
Sokol H, Seksik P, Rigottier-Gois L, et al: Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis 2006;12:106-111.
62.
To N, Gracie DJ, Ford AC: The importance of smoking cessation in improving disease course in Crohn's disease. Am J Gastroenterol 2016;111:1198.
63.
Quezada SM, Langenberg P, Cross RK: Cigarette smoking adversely affects disease activity and disease-specific quality of life in patients with Crohn's disease at a tertiary referral center. Clin Exp Gastroenterol 2016;9:307-310.
64.
Jiang XL, Cui HF: An analysis of 10218 ulcerative colitis cases in China. World J Gastroenterol 2002;8:158-161.
65.
Pugazhendhi S, Sahu MK, Subramanian V, Pulimood A, Ramakrishna BS: Environmental factors associated with Crohn's disease in India. Indian J Gastroenterol 2011;30:264-269.
66.
Sood A, Amre D, Midha V, et al: Low hygiene and exposure to infections may be associated with increased risk for ulcerative colitis in a North Indian population. Ann Gastroenterol 2014;27:219-223.
67.
Ng SC, Tang W, Leong RW, et al; Asia-Pacific Crohn's and Colitis Epidemiology Study ACCESS Group: Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut 2015;64:1063-1071.
68.
Kalaria R, Desai D, Abraham P, Joshi A, Gupta T, Shah S: Temporal change in phenotypic behaviour in patients with Crohn's disease: do Indian patients behave differently from Western and other Asian patients? J Crohns Colitis 2016;10:255-261.
69.
Rai T, Choudhury BN, Kedia S, Bopanna S, Venigalla PM, Garg SK, Singla V, Makharia G, Ahuja V: Short-term clinical response to corticosteroids can predict long-term natural history of ulcerative colitis: prospective study experience. Dig Dis Sci 2017;62:1025-1034.
70.
Dinesen LC, Walsh AJ, Protic MN, et al: The pattern and outcome of acute severe colitis. J. Crohns Colitis 2010;4:431-437.
71.
Jain S, Kedia S, Sethi T, et al: Long-term outcome after acute severe ulcerative colitis in India. Indian J Gastroenterol 2016;35(suppl 1):A1-A111.
72.
Gustavsson A, Halfvarson J, Magnuson A, et al: Long-term colectomy rate after intensive intravenous corticosteroid therapy for ulcerative colitis prior to the immunosuppressive treatment era. Am J Gastroenterol 2007;102:2513-2519.
73.
Bojic D, Radojicic Z, Nedeljkovic-Protic M, et al: Long-term outcome after admission for acute severe ulcerative colitis in Oxford: the 1992-1993 cohort. Inflamm Bowel Dis 2009;15:823-828.
74.
Molnár T, Farkas K, Nyári T, et al: Response to first intravenous steroid therapy determines the subsequent risk of colectomy in ulcerative colitis patients. J. Gastrointest Liver Dis JGLD 2011;20:359-363.
75.
Lee H-S, Yang S-K, Soh JS, et al: Short- and long-term outcomes of acute severe ulcerative colitis in Korea: the 1999-2005 cohort. Inflamm Bowel Dis 2015;21:1825-1831.
76.
Pratap Mouli V, Munot K, Ananthakrishnan A, et al: Endoscopic and clinical responses to anti-tubercular therapy can differentiate intestinal tuberculosis from Crohn's disease. Aliment Pharmacol Ther 2017;45:27-36.
77.
Pokharna RK, Kabra PK, Sharma R, Kochar DK: Extraintestinal manifestations of idiopathic ulcerative colitis in northwestern India. Indian J Gastroenterol 2004;23:89-90.
78.
Kochhar R, Mehta SK, Nagi B, Bhatia V, Goenka MK, Malik AK: Extraintestinal manifestations of idiopathic ulcerative colitis. Indian J Gastroenterol 1991;10:88-89.
79.
Bandyopadhyay D, Bandyopadhyay S, Ghosh P, et al: Extraintestinal manifestations in inflammatory bowel disease: prevalence and predictors in Indian patients. Indian J Gastroenterol 2015;34:387-394.
80.
Singh B, Kedia S, Konijeti G, et al: Extraintestinal manifestations of inflammatory bowel disease and intestinal tuberculosis: frequency and relation with disease phenotype. Indian J Gastroenterol 2015;34:43-50.
81.
Greenstein AJ, Janowitz HD, Sachar DB: The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 1976;55:401-412.
82.
Mendoza JL, Lana R, Taxonera C, Alba C, Izquierdo S, Díaz-Rubio M: Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn's disease and ulcerative colitis (in Spanish). Med Clin (Barc) 2005;125:297-300.
83.
Aghazadeh R, Zali MR, Bahari A, Amin K, Ghahghaie F, Firouzi F: Inflammatory bowel disease in Iran: a review of 457 cases. J Gastroenterol Hepatol 2005;20:1691-1695.
84.
Kim ES, Kim WH: Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics. Gut Liver 2010;4:1-14.
85.
Pongprasobchai S, Manatsathit S, Leelakusolvong S, Sattawatthamrong Y, Boonyapisit S: Ulcerative colitis in Thailand: a clinical study and long term follow-up. J Med Assoc Thai 2001;84:1281-1288.
86.
Rasmussen HH, Fallingborg J, Mortensen PB, Freund L, Tage-Jensen U, Kruse V, Rasmussen SN: Primary sclerosing cholangitis in patients with ulcerative colitis. Scand J Gastroenterol 1992;27:732-736.
87.
Amarapurkar DN, Patel ND: Spectrum of autoimmune liver diseases in western India. J Gastroenterol Hepatol 2007;22:2112-2117.
88.
Gupta R, Agarwal SR, Jain M, Malhotra V, Sarin SK: Autoimmune hepatitis in the Indian subcontinent: 7 years experience. J Gastroenterol Hepatol 2001;16:1144-1148.
89.
Monsén U, Broström O, Nordenvall B, Sörstad J, Hellers G: Prevalence of inflammatory bowel disease among relatives of patients with ulcerative colitis. Scand J Gastroenterol 1987;22:214-218.
90.
Yang H, McElree C, Roth MP, Shanahan F, Targan SR, Rotter JI: Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut 1993;34:517-524.
91.
Gupta A, Bopanna A, Kedia S, et al: Familial aggregation of inflammatory bowel disease in patients of ulcerative colitis. Intes Res (abstract).
92.
Niriella MA, De Silva AP, Dayaratne AH, et al: Prevalence of inflammatory bowel disease in two districts of Sri Lanka: a hospital based survey. BMC Gastroenterol 2010;10:32.
93.
Kuwahara E, Asakura K, Nishiwaki Y, et al: Effects of family history on inflammatory bowel disease characteristics in Japanese patients. J Gastroenterol 2012;47:961-968.
94.
Chung SH, Park SJ, Lee HS, et al: Similar clinical characteristics of familial and sporadic inflammatory bowel disease in South Korea. World J Gastroenterol 2014;20:17120-17126.
95.
Hwang SW, Kwak MS, Kim WS, et al: Influence of a positive family history on the clinical course of inflammatory bowel disease. J Crohns Colitis 2016;10:1024-1032.
96.
Padhan RK, Kedia S, Garg SK, et al: Long-term disease course and pregnancy outcomes in women with inflammatory bowel disease: an Indian cohort study. Dig Dis Sci 2016, Epub ahead of print.
97.
Riis L, Vind I, Politi P, et al; European Collaborative study group on Inflammatory Bowel Disease: Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease. Am J Gastroenterol 2006;101:1539-1545.
98.
Ferlay J, Shin HR, Bray F, et al: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-2917.
99.
Kochhar R, Goenka MK, Kaushik SP, et al: Colorectal carcinoma in Indian patients with idiopathic ulcerative colitis. Eur J Cancer Prev 1992;1:293-296.
100.
Venkataraman S, Mohan V, Ramakrishna B, et al: Risk of colorectal cancer in ulcerative colitis in India. J Gastroenterol Hepatol 2005;20:705-709.
101.
Desai D, Shah S, Deshmukh A, et al: Colorectal cancers in ulcerative colitis from a low-prevalence area for colon cancer. World J Gastroenterol 2015;21:3644-3649.
102.
Bopanna S, Kedia S, Das P, et al: Long-term follow-up reveals high incidence of colorectal cancer in Indian patients with inflammatory bowel disease. United European Gastroenterol J 2016, DOI: 10.1177/ 2050640616680552.
103.
Eaden JA, Abrams KR, Mayberry JF: The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526-535.
104.
Bopanna S, Ananthakrishnan A, Kedia S, Yajnik V, Ahuja V: Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2017;2:269-276.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.